DE69302677T2 - Liposomale piroxycam formulierung - Google Patents

Liposomale piroxycam formulierung

Info

Publication number
DE69302677T2
DE69302677T2 DE69302677T DE69302677T DE69302677T2 DE 69302677 T2 DE69302677 T2 DE 69302677T2 DE 69302677 T DE69302677 T DE 69302677T DE 69302677 T DE69302677 T DE 69302677T DE 69302677 T2 DE69302677 T2 DE 69302677T2
Authority
DE
Germany
Prior art keywords
amount
composition
piroxicam
phospholipid
tetraglycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69302677T
Other languages
German (de)
English (en)
Other versions
DE69302677D1 (de
Inventor
Giuseppe Assogna
Pietro Bagnato
Giovanni Lucchetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Cilag SpA
Original Assignee
Janssen Cilag SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Cilag SpA filed Critical Janssen Cilag SpA
Priority claimed from PCT/EP1993/000272 external-priority patent/WO1993015718A1/en
Publication of DE69302677D1 publication Critical patent/DE69302677D1/de
Application granted granted Critical
Publication of DE69302677T2 publication Critical patent/DE69302677T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69302677T 1992-02-12 1993-02-04 Liposomale piroxycam formulierung Expired - Fee Related DE69302677T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92200398 1992-02-12
PCT/EP1993/000272 WO1993015718A1 (en) 1992-02-12 1993-02-04 Liposomal piroxicam formulations

Publications (2)

Publication Number Publication Date
DE69302677D1 DE69302677D1 (de) 1996-06-20
DE69302677T2 true DE69302677T2 (de) 1996-10-02

Family

ID=8210420

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69302677T Expired - Fee Related DE69302677T2 (de) 1992-02-12 1993-02-04 Liposomale piroxycam formulierung

Country Status (13)

Country Link
US (1) US5505960A (cg-RX-API-DMAC10.html)
JP (1) JPH07503952A (cg-RX-API-DMAC10.html)
CN (1) CN1075633A (cg-RX-API-DMAC10.html)
AT (1) ATE137959T1 (cg-RX-API-DMAC10.html)
AU (1) AU661755B2 (cg-RX-API-DMAC10.html)
CA (1) CA2129624A1 (cg-RX-API-DMAC10.html)
DE (1) DE69302677T2 (cg-RX-API-DMAC10.html)
DK (1) DK0625898T3 (cg-RX-API-DMAC10.html)
ES (1) ES2090966T3 (cg-RX-API-DMAC10.html)
IL (1) IL104688A0 (cg-RX-API-DMAC10.html)
MX (1) MX9300707A (cg-RX-API-DMAC10.html)
TW (1) TW262382B (cg-RX-API-DMAC10.html)
ZA (1) ZA93954B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE414542T1 (de) * 2000-12-19 2008-12-15 Univ Texas Nsaid zusammensetzungen enthaltend lecithinöl zum schutz des magen-darm-traktes und zur erhöhten therapeutischen wirkung
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
EP1653975A4 (en) * 2003-07-31 2006-10-25 Univ Texas COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND / OR PREVENTING CANCER, THE USE OF CANCER OR THE SYMPTOMS OF CANCER
CA2650007A1 (en) 2006-04-21 2007-11-01 Smithkline Beecham Corporation Il-8 receptor antagonists
WO2010056833A1 (en) * 2008-11-12 2010-05-20 Archer Daniels Midland Company Lecithin and plasticizer compositions and methods
CN101637451B (zh) * 2009-06-12 2011-03-30 陶灵刚 一种氯诺昔康脂质体药物组合物及其固体制剂
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
US8906397B2 (en) 2011-02-07 2014-12-09 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US20120201871A1 (en) * 2011-02-07 2012-08-09 Professional Compounding Centers Of America, Ltd. Permeation enhancers with liposomes for topical formulations
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
US9415054B2 (en) 2013-06-13 2016-08-16 Professional Compounding Centers Of America (Pcca) Piroxicam transdermal composition to treat plantar fasciitis
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
ES2036593T3 (es) * 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
BE1000381A4 (fr) * 1987-03-13 1988-11-16 Pharlyse Sa Preparation pharmaceutique a base d'indometacine.
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
ATE137959T1 (de) 1996-06-15
DE69302677D1 (de) 1996-06-20
CA2129624A1 (en) 1993-08-19
CN1075633A (zh) 1993-09-01
AU661755B2 (en) 1995-08-03
TW262382B (cg-RX-API-DMAC10.html) 1995-11-11
MX9300707A (es) 1994-01-31
IL104688A0 (en) 1993-06-10
DK0625898T3 (da) 1996-06-03
ES2090966T3 (es) 1996-10-16
ZA93954B (en) 1994-08-11
JPH07503952A (ja) 1995-04-27
AU3495093A (en) 1993-09-03
US5505960A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
DE69302897T2 (de) Liposomale itraconazol formulierungen
DE69525761T2 (de) MITTEL MIT GESTEUERTER FREISETZUNG, DIE EINE UMGEKEHRTE MICELLARE (L2) STRUKTUR ODER EINE NORMALE MICELLARE (l1) STRUKTUR BILDEN
DE4430593C2 (de) Verfahren zur Herstellung von Liposomal verkapseltem Taxol
DE3785198T3 (de) Liposomes präparat und antibiotikum.
DE69526655T2 (de) Wässrige emulsion mit kontrollierter freisetzung
DE69029804T2 (de) VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
DE69628909T2 (de) Liposomformulierung von 5-beta steroiden
EP0733372A2 (de) Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
EP0711557A1 (de) Pharmazeutische Formulierungsgrundlage
DE69029100T2 (de) Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
EP0011745B1 (de) Kolloide wässrige Zusammensetzung für pharmazeutische Zwecke, und deren Herstellung
WO1994003156A1 (de) Pharmazeutische und/oder kosmetische zubereitung sowie die verwendung einer derartigen zubereitung
EP0147741B1 (de) Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-Glycero-3-Phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
US5505960A (en) Liposomal piroxicam formulations
DE2914789C2 (cg-RX-API-DMAC10.html)
DE3882984T2 (de) Herstellung einer aus einem pharmakologischen wirkstoff und einem lipid bestehenden lösung.
DE69813287T2 (de) Lipidzusammensetzungen und deren verwendung
DE4110779A1 (de) Liposomale formulierungen antimykotischer, antibakterieller und/oder antiphlogistischer arzneimittel fuer die lokale und vaginale anwendung
EP0523418A1 (de) Verfahren zur Herstellung von stabilen, hydrophilen oder ambiphilen Creme-Zubereitungen, enthaltend vesikuläre Bestandteile, und deren Verwendung
DE60307358T2 (de) Zubereitung zur Verabreichung von Dithranol
EP0615746B1 (de) Wässriges Liposomensystem sowie Verfahren zur Herstellung eines derartigen Liposomensystems
DE69132211T2 (de) Synthetische oberflächenaktive agentien auf der lunge
DE10148065A1 (de) (Ester)-Lysolecithine in Liposomen
DE60123132T2 (de) Liposomenformulierung mit clobetasol propionate
DE3851842T2 (de) Wässrige bereitung von liposomenzusammensetzungen.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: JANSSEN-CILAG S.P.A., MILAN, IT

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee